Bio-Rad Laboratories Class A
326 hedge funds and large institutions have $5.42B invested in Bio-Rad Laboratories Class A in 2018 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 109 increasing their positions, 126 reducing their positions, and 29 closing their positions.
38% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 29
12% more capital invested
Capital invested by funds: $4.82B → $5.42B (+$602M)
3% more funds holding
Funds holding: 316 → 326 (+10)
8% more call options, than puts
Call options by funds: $2.45M | Put options by funds: $2.28M
0.73% less ownership
Funds ownership: 78.3% → 77.57% (-0.73%)
13% less repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 126
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$81.3M |
| 2 |
Goldman Sachs
New York
|
+$29.7M |
| 3 |
CCI
Columbus Circle Investors
|
+$23.1M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$19.7M |
| 5 |
SEI Investments
Oaks,
Pennsylvania
|
+$16.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$25.7M |
| 2 |
SC
Samlyn Capital
New York
|
-$22.4M |
| 3 |
EIP
Epoch Investment Partners
New York
|
-$20.7M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$20.6M |
| 5 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$19.7M |
BIO Hedge Fund Activity: Q2 2018 in Review
326 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q2 2018, worth a combined $5.42B — up 12% from $4.82B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new BIO positions and 29 closed out — a net gain of 11 holders — while 109 added to existing stakes and 126 trimmed.
The largest buyer was Millennium Management, adding an estimated $81.3M. The largest seller was HealthCor Management, exiting entirely with an estimated $25.7M sold.
- 326 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q2 2018, up from 316 in Q1 2018.
- Funds reported $5.42B of Bio-Rad Laboratories Class A stock for Q2 2018, up 12% quarter-over-quarter.
- 40 funds opened new Bio-Rad Laboratories Class A positions in Q2 2018 and 29 closed out, a net change of +11 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q2 2018 was Millennium Management, an estimated $81.3M added.
- The largest Bio-Rad Laboratories Class A seller in Q2 2018 was HealthCor Management, an estimated $25.7M sold.
Based on aggregated 13F filings for Q2 2018.